These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11304736)

  • 21. A systematic survey of the methods literature on the reporting quality and optimal methods of handling participants with missing outcome data for continuous outcomes in randomized controlled trials.
    Zhang Y; Alyass A; Vanniyasingam T; Sadeghirad B; Flórez ID; Pichika SC; Kennedy SA; Abdulkarimova U; Zhang Y; Iljon T; Morgano GP; Colunga Lozano LE; Aloweni FAB; Lopes LC; Yepes-Nuñez JJ; Fei Y; Wang L; Kahale LA; Meyre D; Akl EA; Thabane L; Guyatt GH
    J Clin Epidemiol; 2017 Aug; 88():67-80. PubMed ID: 28579378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A bias correction in testing treatment efficacy under informative dropout in clinical trials.
    Kong F; Chen YF; Jin K
    J Biopharm Stat; 2009 Nov; 19(6):980-1000. PubMed ID: 20183460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk-stratified imputation in survival analysis.
    Kennedy RE; Adragni KP; Tiwari HK; Voeks JH; Brott TG; Howard G
    Clin Trials; 2013 Aug; 10(4):530-9. PubMed ID: 23818434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation and comparison of rates of change in longitudinal studies with informative drop-outs.
    Touloumi G; Pocock SJ; Babiker AG; Darbyshire JH
    Stat Med; 1999 May; 18(10):1215-33. PubMed ID: 10363341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An alternative parameterization of the general linear mixture model for longitudinal data with non-ignorable drop-outs.
    Fitzmaurice GM; Laird NM; Shneyer L
    Stat Med; 2001 Apr; 20(7):1009-21. PubMed ID: 11276032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity analysis of incomplete longitudinal data departing from the missing at random assumption: Methodology and application in a clinical trial with drop-outs.
    Moreno-Betancur M; Chavance M
    Stat Methods Med Res; 2016 Aug; 25(4):1471-89. PubMed ID: 23698867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of weighted estimating equations for longitudinal binary data with drop-outs missing at random.
    Preisser JS; Lohman KK; Rathouz PJ
    Stat Med; 2002 Oct; 21(20):3035-54. PubMed ID: 12369080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of dropouts on the analysis of dose-finding studies with recurrent event data.
    Akacha M; Benda N
    Stat Med; 2010 Jul; 29(15):1635-46. PubMed ID: 20552569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.
    Yang X; Shoptaw S
    Drug Alcohol Depend; 2005 Mar; 77(3):213-25. PubMed ID: 15734221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pattern-mixture model with nonfuture dependence and shift in current missing values.
    Lu K; Chen C; Li D
    J Biopharm Stat; 2015; 25(3):548-69. PubMed ID: 24905193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A profile analysis approach using MMRM in acute schizophrenia: a comparison to some traditional approaches.
    Stiger TR; Banerjee A
    J Biopharm Stat; 2013; 23(6):1372-82. PubMed ID: 24138437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology.
    Leon AC; Mallinckrodt CH; Chuang-Stein C; Archibald DG; Archer GE; Chartier K
    Biol Psychiatry; 2006 Jun; 59(11):1001-5. PubMed ID: 16503329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allowing for uncertainty due to missing and LOCF imputed outcomes in meta-analysis.
    Mavridis D; Salanti G; Furukawa TA; Cipriani A; Chaimani A; White IR
    Stat Med; 2019 Feb; 38(5):720-737. PubMed ID: 30347460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drop-outs and a random regression model.
    Overall JE
    J Biopharm Stat; 1997 Jul; 7(3):383-402. PubMed ID: 9252832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simulation-based study comparing multiple imputation methods for non-monotone missing ordinal data in longitudinal settings.
    Donneau AF; Mauer M; Lambert P; Molenberghs G; Albert A
    J Biopharm Stat; 2015; 25(3):570-601. PubMed ID: 24905056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting missing quality of life data that were later recovered: an empirical comparison of approaches.
    Fielding S; Fayers P; Ramsay C
    Clin Trials; 2010 Aug; 7(4):333-42. PubMed ID: 20576672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity analysis of longitudinal normal data with drop-outs.
    Minini P; Chavance M
    Stat Med; 2004 Apr; 23(7):1039-54. PubMed ID: 15057877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the random-effects pattern mixture model with last-observation-carried-forward (LOCF) analysis in longitudinal clinical trials with dropouts.
    Siddiqui O; Ali MW
    J Biopharm Stat; 1998 Nov; 8(4):545-63. PubMed ID: 9855033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of handling missing data for treatment response in osteoarthritis: a simulation study.
    Olsen IC; Kvien TK; Uhlig T
    Osteoarthritis Cartilage; 2012 Aug; 20(8):822-8. PubMed ID: 22441031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sample size estimation for repeated measures analysis in randomized clinical trials with missing data.
    Lu K; Luo X; Chen PY
    Int J Biostat; 2008; 4(1):Article 9. PubMed ID: 22462117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.